Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Călugăru D, Călugăru M . Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 2015; 31: 78–86.
Campochiaro PA, Hafiz G, Mir TA, Scott AW, Solomon S, Zimmer-Galler I et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmology 2015; 122: 1426–1437.
Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology 2012; 119: 802–809.
CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ . Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364: 1897–1908.
Campochiaro PA, Wykoff CC, Singer M, Johnson R, Marcus D, Yau L et al. Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study. Ophthalmology 2014; 121: 2432–2442.
Papakostas TD, Lim L, van Zyl T, Miller JB, Modjtahedi BS, Andreoli CM et al. Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab. Eye (Lond) 2016; 30 (1): 79–84.
Lehmann-Clarke L, Dirani A, Mantel I, Ambresin A . The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion. Klin Monbl Augenheilkd 2015; 232: 552–555.
Pfau M, Fassnacht-Riederle H, Becker MD, Graf N, Michels S . Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion. Ophthalmic Res 2015; 54: 150–156.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ashraf, M., Souka, A. & Singh, R. Response to: ‘Comment on Central retinal vein occlusion: modifying current treatment protocols’. Eye 30, 1396–1397 (2016). https://doi.org/10.1038/eye.2016.84
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2016.84
